(Q42636217)

4 November 2017

title

Long-Term use of quetiapine in elderly patients with psychotic disorders (English)

1 reference

4 November 2017

1 reference

Tariot PN

1

1 reference

4 November 2017

Salzman C

2

1 reference

4 November 2017

Yeung PP

3

1 reference

4 November 2017

Pultz J

4

1 reference

4 November 2017

Rak IW

5

1 reference

4 November 2017

publication date

1 September 2000

1 reference

4 November 2017

published in

Clinical Therapeutics

1 reference

4 November 2017

volume

22

1 reference

4 November 2017

issue

9

1 reference

4 November 2017

page(s)

1068-1084

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

4 November 2017

1 reference

7 January 2021

Pharmacological management of schizophrenia in older patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Six-month prevalence of psychiatric disorders in three communities 1980 to 1982.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Epidemiology of psychotherapeutic drug use in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Clinical profile of clozapine: adverse reactions and agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Reversal by physostigmine of clozapine-induced delirium

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Absence of vascular dementia in an autopsy series from a dementia clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

Dizziness and falling in elderly psychiatric outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980085-5

7 January 2021

10.1016/S0149-2918(00)80085-5

Identifiers

DOI

1 reference

4 November 2017

1 reference